Hormone Therapy May Mitigate Obesity Related Cancer Risk

Get the Flash Player to see the wordTube Media Player.

A lack of hormone therapy may contribute to a higher cancer risk for obese women. A seven-year-long study looked at almost a HUNDRED THOUSAND women ages 50 to 71 and found that obese women were no more likely to get ovarian cancer than their thinner sisters– IF they used hormone replacement therapy.

However, women with obesity who had NEVER used hormone replacement therapy were almost TWO TIMES more likely to develop ovarian cancer than women of normal weight.

So why do obese women who don’t take their hormones run a higher risk of ovarian cancer? It could be a concentration of surplus ESTROGEN produced by the fat cells in the body, according to Dr. Michael Leitzmann, one of the researchers of the study.  But, the jury is still out.

If you’ve been prescribed hormone therapy, it might help prevent obesity related cancers.

About The Author

Leave a Reply

Your email address will not be published.

*